Mary DiBiase
Chief Operating Officer at X4 PHARMACEUTICALS, INC.
Net worth: 405 535 $ as of 2024-03-30
Profile
Mary DiBiase is currently the Chief Operating Officer at X4 Pharmaceuticals, Inc. She started this position in 2021.
Prior to her current role, she held several positions in the pharmaceutical industry.
From 1995 to 2011, she worked at Biogen, Inc. as a Senior Director-CMC Management.
In 2011, she joined Pfizer Inc. as the Vice President-Product Operations.
From 2013 to 2016, she worked at EPIRUS Biopharmaceuticals, Inc. as the VP-Technical Operations & Program Management.
Dr. DiBiase holds a doctorate degree from the University of Rhode Island and an undergraduate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0.17% | 2024-03-10 | 291,752 ( 0.17% ) | 405 535 $ | 2024-03-30 |
Mary DiBiase active positions
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Operating Officer | 2021-09-07 |
Former positions of Mary DiBiase
| Companies | Position | End |
|---|---|---|
| EPIRUS BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
| PFIZER, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | 2010-12-31 |
Training of Mary DiBiase
| University of Rhode Island | Doctorate Degree |
| University of London | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Mary DiBiase